A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer

S. C. Oh, H. Y. Sur, H. J. Sung, I. K. Choi, S. S. Park, J. H. Seo, Y. T. Jeen, H. J. Chun, S. W. Shin, Y. J. Mok, J. S. Kim, Y. H. Kim

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences